Maryland State Retirement & Pension System Cuts Holdings in AVANOS MEDICAL, INC. $AVNS

Maryland State Retirement & Pension System lessened its stake in AVANOS MEDICAL, INC. (NYSE:AVNS) by 13.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 13,411 shares of the company’s stock after selling 2,106 shares during the quarter. Maryland State Retirement & Pension System’s holdings in AVANOS MEDICAL were worth $192,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of AVNS. Charles Schwab Investment Management Inc. grew its stake in shares of AVANOS MEDICAL by 32.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 608,635 shares of the company’s stock worth $8,722,000 after purchasing an additional 148,619 shares in the last quarter. Cary Street Partners Financial LLC purchased a new stake in AVANOS MEDICAL during the 1st quarter worth about $226,000. US Bancorp DE boosted its position in shares of AVANOS MEDICAL by 7.7% during the 1st quarter. US Bancorp DE now owns 15,184 shares of the company’s stock worth $218,000 after acquiring an additional 1,091 shares in the last quarter. Clark Estates Inc. NY purchased a new position in shares of AVANOS MEDICAL in the 1st quarter valued at about $7,077,000. Finally, Pacer Advisors Inc. acquired a new stake in shares of AVANOS MEDICAL during the 1st quarter worth about $6,056,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at AVANOS MEDICAL

In other news, Director Gary Blackford bought 40,000 shares of AVANOS MEDICAL stock in a transaction on Wednesday, August 13th. The shares were bought at an average cost of $10.99 per share, for a total transaction of $439,600.00. Following the acquisition, the director owned 40,000 shares in the company, valued at approximately $439,600. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 2.64% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages recently issued reports on AVNS. Wall Street Zen downgraded AVANOS MEDICAL from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 9th. Zacks Research upgraded AVANOS MEDICAL to a “hold” rating in a research report on Tuesday, August 12th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold”.

AVANOS MEDICAL Stock Up 2.0%

AVNS opened at $11.4780 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.58 and a current ratio of 2.64. The company has a market cap of $532.58 million, a price-to-earnings ratio of -1.14 and a beta of 1.12. AVANOS MEDICAL, INC. has a one year low of $9.30 and a one year high of $25.36. The business’s fifty day moving average is $11.71 and its two-hundred day moving average is $13.11.

AVANOS MEDICAL (NYSE:AVNS) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). AVANOS MEDICAL had a positive return on equity of 6.16% and a negative net margin of 66.89%.The firm had revenue of $175.00 million for the quarter, compared to analyst estimates of $165.50 million. During the same period last year, the firm earned $0.34 EPS. AVANOS MEDICAL has set its FY 2025 guidance at 0.750-0.950 EPS. Analysts anticipate that AVANOS MEDICAL, INC. will post 1.32 EPS for the current fiscal year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.